Procter & Gamble Hygiene and Health Care Limited (PGHH.BO)
INR 15346.65
(-0.65%)
INR 15346.65
(-0.65%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | - INR | -100.0% |
| 2022 | 8.4 Million INR | -56.7% |
| 2021 | 19.4 Million INR | 977.78% |
| 2020 | 1.8 Million INR | -87.76% |
| 2019 | 14.7 Million INR | 0.0% |
| 2018 | - INR | 0.0% |
| 2017 | - INR | 0.0% |
| 2016 | - INR | 0.0% |
| 2015 | - INR | 0.0% |
| 2014 | - INR | 0.0% |
| 2013 | - INR | 0.0% |
| 2012 | - INR | -100.0% |
| 2011 | 3.56 Million INR | 0.0% |
| 2010 | 3.56 Million INR | 0.0% |
| 2009 | - INR | 0.0% |
| 2008 | - INR | 0.0% |
| 2007 | - INR | 0.0% |
| 2006 | - INR | 0.0% |
| 2005 | - INR | 0.0% |
| 2004 | - INR | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 Q2 | 2.6 Million INR | 0.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q4 | - INR | 0.0% |
| 2023 FY | - INR | -100.0% |
| 2023 Q3 | - INR | -100.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q4 | 8.4 Million INR | 0.0% |
| 2022 FY | 8.4 Million INR | -56.7% |
| 2022 Q2 | 13.7 Million INR | 0.0% |
| 2022 Q1 | - INR | -100.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q2 | 800 Thousand INR | 0.0% |
| 2021 Q4 | 19.4 Million INR | 0.0% |
| 2021 FY | 19.4 Million INR | 977.78% |
| 2021 Q1 | - INR | -100.0% |
| 2020 Q4 | 1.8 Million INR | 0.0% |
| 2020 Q1 | - INR | -100.0% |
| 2020 FY | 1.8 Million INR | -87.76% |
| 2020 Q2 | 5.2 Million INR | 0.0% |
| 2020 Q3 | - INR | -100.0% |
| 2019 Q3 | - INR | 0.0% |
| 2019 Q4 | 14.7 Million INR | 0.0% |
| 2019 Q1 | - INR | 0.0% |
| 2019 FY | 14.7 Million INR | 0.0% |
| 2019 Q2 | - INR | 0.0% |
| 2018 Q2 | - INR | 0.0% |
| 2018 FY | - INR | 0.0% |
| 2018 Q4 | - INR | 0.0% |
| 2018 Q3 | - INR | 0.0% |
| 2018 Q1 | - INR | 0.0% |
| 2017 Q4 | - INR | 0.0% |
| 2017 Q3 | - INR | 0.0% |
| 2017 Q1 | - INR | 0.0% |
| 2017 Q2 | - INR | 0.0% |
| 2017 FY | - INR | 0.0% |
| 2016 Q3 | - INR | 0.0% |
| 2016 FY | - INR | 0.0% |
| 2016 Q4 | - INR | 0.0% |
| 2016 Q1 | - INR | 0.0% |
| 2016 Q2 | - INR | 0.0% |
| 2015 Q2 | - INR | 0.0% |
| 2015 Q3 | - INR | 0.0% |
| 2015 FY | - INR | 0.0% |
| 2015 Q4 | - INR | 0.0% |
| 2015 Q1 | - INR | 0.0% |
| 2014 Q2 | - INR | 0.0% |
| 2014 FY | - INR | 0.0% |
| 2014 Q4 | - INR | 0.0% |
| 2014 Q3 | - INR | 0.0% |
| 2014 Q1 | - INR | 0.0% |
| 2013 Q3 | - INR | 0.0% |
| 2013 Q4 | - INR | 0.0% |
| 2013 FY | - INR | 0.0% |
| 2013 Q1 | - INR | 0.0% |
| 2013 Q2 | - INR | 0.0% |
| 2012 Q2 | - INR | 0.0% |
| 2012 Q3 | - INR | 0.0% |
| 2012 FY | - INR | -100.0% |
| 2012 Q4 | - INR | 0.0% |
| 2011 FY | 3.56 Million INR | 0.0% |
| 2011 Q4 | 3.56 Million INR | 0.0% |
| 2010 Q4 | 3.56 Million INR | 0.0% |
| 2010 FY | 3.56 Million INR | 0.0% |
| 2009 FY | - INR | 0.0% |
| 2008 FY | - INR | 0.0% |
| 2007 FY | - INR | 0.0% |
| 2006 FY | - INR | 0.0% |
| 2005 FY | - INR | 0.0% |
| 2004 FY | - INR | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Ador Multiproducts Limited | - INR | NaN% |
| Ambica Agarbathies Aroma & Industries Limited | 673.21 Million INR | 100.0% |
| Bajaj Consumer Care Limited | 39.88 Million INR | 100.0% |
| Colgate-Palmolive (India) Limited | 595.5 Million INR | 100.0% |
| Cupid Limited | - INR | NaN% |
| Dabur India Limited | 5.35 Billion INR | 100.0% |
| Emami Limited | 154.3 Million INR | 100.0% |
| Gillette India Limited | 500 Thousand INR | 100.0% |
| Godrej Consumer Products Limited | 358.3 Million INR | 100.0% |
| Hindustan Unilever Limited | 11.06 Billion INR | 100.0% |
| Hipolin Limited | - INR | NaN% |
| Honasa Consumer Limited | 1.12 Billion INR | 100.0% |
| JHS Svendgaard Laboratories Limited | 1.18 Million INR | 100.0% |
| Jyothy Labs Limited | 259.1 Million INR | 100.0% |
| Kaya Limited | 1.41 Billion INR | 100.0% |
| Marico Limited | 1.04 Billion INR | 100.0% |
| N.K Industries Limited | - INR | NaN% |
| PAOS INDUSTRIES LIMITED | 163.74 Million INR | 100.0% |
| Paramount Cosmetics (India) Limited | 60.93 Million INR | 100.0% |
| Pee Cee Cosma Sope Limited | 4.91 Million INR | 100.0% |